Law360, New York (February 21, 2007, 12:00 AM EST) -- The U.S. Food and Drug Administration on Wednesday ordered manufacturers of drugs prescribed to treat attention deficit hyperactivity disorder to develop guides to alert patients of possible risks, including mental problems, heart problems and sudden death.
The agency said it has directed the manufacturers of all drug products approved for the treatment of ADHD to develop patient medication guides to alert patients to possible cardiovascular risks and risks of adverse psychiatric symptoms associated with the medicines, and to advise them of precautions that can be taken....
ADHD Drug Makers Must Warn Of Side Effects: FDA
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
